ICUI
ICU Medical, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +11.8% ·
share flow +3.0% ·
net new positions +5.3%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +1 | 16.65M | $2.44B | +7 | −7 |
| Q1 2026 | 104 | -4 | 18.58M | $2.40B | +5 | −10 |
| Q4 2025 | 108 | +2 | 19.90M | $2.83B | +3 | — |
| Q3 2025 | 19 | +2 | 11.89M | $1.43B | +3 | −2 |
| Q2 2025 | 15 | -1 | 9.62M | $1.27B | — | −1 |
| Q1 2025 | 13 | +1 | 2.74M | $379.97M | +2 | −1 |
| Q4 2024 | 12 | 0 | 3.47M | $538.76M | — | — |
| Q3 2024 | 11 | -2 | 3.16M | $575.79M | — | −2 |
| Q2 2024 | 13 | — | 2.88M | $341.58M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 3.52M | -1.2% | $422.45M | 0.0% | ▼ Trim | 2 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (passive) | 2.62M | -1.3% | $314.89M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | JPMorgan Chase ✦ | 1.35M | — | $162.27M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 4 | Millennium Management ✦ | 1.09M | +173.4% | $130.64M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passive) | 917.12K | -1.1% | $110.02M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 593.33K | -1.8% | $71.19M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 565.19K | — | $67.80M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 8 | Fidelity (FMR) ✦ | 365.28K | -19.0% | $43.82M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 9 | Goldman Sachs Group ✦ | 278.71K | — | $33.43M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 237.79K | +75.6% | $28.53M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 11 | Adage Capital Partners ✦ | 119.86K | New | $14.38M | 0.0% | New | 1 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 69.40K | -19.9% | $8.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 51.90K | -86.4% | $6.23M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 41.04K | +41.4% | $4.92M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 25.06K | +2.4% | $3.01M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 22.98K | +5.6% | $2.76M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 8.74K | +1.9% | $1.05M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 18 | Arrowstreet Capital ✦ | 3.46K | New | $415,661 | 0.0% | New | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 2.54K | New | $304,698 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $14.38M | 0.0% |
| Arrowstreet Capital | $415,661 | 0.0% |
| Marshall Wace | $304,698 | 0.0% |
Exited
| Norges Bank | $36.63M | was 0.0% |
| D. E. Shaw & Co. | $7.45M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 273 holders, 24.54M shares, $3.09B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 724 sh · $122,736
Officer · 2.20K sh · $369,203
Officer · 1.24K sh · $208,523
Officer · 692 sh · $118,688
Officer · 6.38K sh · $1.12M
Officer · 4.57K sh · $792,291
Officer · 1.71K sh · $292,843
Officer · 1.91K sh · $329,443
Officer · 1.11K sh · $193,567
Officer · 5.42K sh · $982,265
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology